GSK and Ionis Announce Major Win Against Hepatitis B in Landmark Trials
GSK and Ionis announce breakthrough results for bepirovirsen, a potential first-in-class treatment offering functional cure for chronic hepatitis B in just six months.
/ 907 items
#Healthcare↓
Lilly Acquires Ventyx Biosciences for $1.2 Billion to Expand Inflammation Treatment Pipeline
Eli Lilly acquires Ventyx Biosciences for $1.2 billion to advance oral therapies targeting chronic inflammation in heart, brain, and autoimmune diseases.
Ziihera GEA Trial: Modest Gains Come With Severe Side Effects
Jazz new stomach cancer drug extends survival by 7 months but causes severe side effects in 25% of patients. Ziihera-only combination failed to achieve statistical significance for overall survival at first analysis.
Stereotaxis Gets FDA Green Light for Robot-Controlled Heart Catheter
Stereotaxis receives FDA approval for MAGiC catheter, a magnetically-guided robotic device for treating complex heart rhythm disorders in hard-to-reach patients.
Evercore ISI Starts Coverage on UnitedHealth With Bullish View
Evercore ISI initiates UnitedHealth with an Outperform rating and a $400 price target, citing a successful turnaround and long-term growth potential.
Staar Surgical Shareholders Block $1.6B Alcon Acquisition Deal
Staar Surgical shareholders reject Alcon's $1.6 billion takeover bid after activist investor campaign. Company to remain independent on Nasdaq.